Finance

Lists
CMMB:NASDAQ
Chemomab Therapeutics Ltd - ADR
$2.73
+0.37%
(+0.0100) 1D
$2.82
+3.48% (+0.095)
Pre-market
Closed: Sep 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CMMB...
Open
$2.71
High
$2.89
Low
$2.70
Mkt. cap
20.00M
Avg. vol.
91.48K
Volume
371.00
52-wk high
$3.58
52-wk low
$1.35
EPS
-$1.01
Beta
0.65
Shares outstanding
7.19M
No. of employees
12
Open
$2.71
High
$2.89
Low
$2.70
Mkt. cap
20.00M
Avg. vol.
91.48K
Volume
371.00
52-wk high
$3.58
52-wk low
$1.35
EPS
-$1.01
Beta
0.65
Shares outstanding
7.19M
No. of employees
12
About Chemomab Therapeutics Ltd - ADR
CEO-
Employees12
Founded2011
Headquarters-
SectorBiotechnology
Websitechemomab.com
Analyst ratings
Based on 1 analyst giving stock ratings to CMMB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CMMB in the last 3 months
Highest
Current $2.73
$5.00 (+83.15%)
Average
$5.00 (+83.15%)
Lowest
$5.00 (+83.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$5.00
+83.2%
07/13/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$25.00
+815.8%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
960.00K
1.09M
925.00K
1.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
884.00K
881.00K
925.00K
1.10M
Operating expense
1.84M
1.97M
1.85M
2.24M
Total operating expenses
1.84M
1.97M
1.85M
2.24M
Operating income
-1.84M
-1.97M
-1.85M
-2.24M
Other non operating income
-
-
-
-
EBT including unusual items
-1.74M
-1.87M
-1.77M
-2.16M
EBT excluding unusual items
-1.74M
-1.87M
-1.77M
-2.16M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.74M
-1.87M
-1.77M
-2.16M
Net profit margin
-
-
-
-
Earnings per share
-0.00
-0.00
-0.00
-0.00
Interest and investment income
102.00K
-
77.00K
76.00K
Interest expense
-
-24.00K
-
-
Net interest expenses
102.00K
-24.00K
77.00K
76.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.83M
-1.96M
-1.83M
-2.23M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps